These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21602601)

  • 1. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
    Sapa J; Filipek B; Nowiński L
    Pharmacol Rep; 2011; 63(2):455-63. PubMed ID: 21602601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J
    Acta Pol Pharm; 2010; 67(5):537-42. PubMed ID: 20873423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
    Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
    Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
    Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L
    Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
    Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
    Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular activity of the chiral xanthone derivatives.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
    Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
    Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J; Nowaczyk A; Kulig K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):13-25. PubMed ID: 20949258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
    Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
    Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
    Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
    Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-cardiovascular activity relationships in a group of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-aminopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Zmudzki P; Pawłowski M; Zygmunt M; Filipek B
    Pharmacol Rep; 2011; 63(2):476-86. PubMed ID: 21602603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice.
    Sapa J; Filipek B; Kulig K; Malawska B
    Pharmacol Rep; 2011; 63(1):71-8. PubMed ID: 21441613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
    Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
    Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values.
    Abrego VH; Martínez-Pérez B; Torres LA; Angeles E; Martínez L; Marroquín-Pascual JL; Moya-Hernández R; Amaro-Recillas HA; Rueda-Jackson JC; Rodríguez-Barrientos D; Rojas-Hernández A
    Eur J Med Chem; 2010 Oct; 45(10):4622-30. PubMed ID: 20705371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
    Groszek G; Bednarski M; Dybała M; Filipek B
    Eur J Med Chem; 2009 Feb; 44(2):809-17. PubMed ID: 18599160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.